Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06208462 ×

NCT06208462

This funder is selected. Its supporting articles are shown below.

NCT062084621

Articles mentioning NCT06208462

1 articles · page 1 of 1

Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) with GEMOX and lenvatinib in combination with adebrelimab for resectable high-risk recurrent intrahepatic cholangiocarcinoma (ICC): study protocol of the NEO-ERA-01 feasibility trial

bmjopen · abstract · 2026-02-23 · 1 matching annotations

86.9%

NCT06208462 Adebrelimab lenvatinib Intrahepatic cholangiocarcinoma oxaliplatin capecitabine gemcitabine ICC Hepatic arterial infusion chemotherapy

…reviewed publications and conferences.Trial registration number NCT06208462.…